retatrutide weight loss clinical trials results Eli Lilly infiltrates anti-obesity market as Phase III trial for begins This data from Phase 3

The choice between Semaglutide, Tirzepatide, and Retatrutide depends on factors like: Your weight loss goals Existing health conditions (e.g., Type 2 Diabetes) How your body responds to GLP-1 medications Your providers recommendations All three medications are highly effective, but Retatrutide may offer the most significant weight loss due to its triple-action mechanism

doi:10.1016/j.bcp.2019.03.024 Yang L, Yang J, Pan T, Zhong X

Hold each step for the full four weeks regardless of how well it is tolerated

This will be alongside my Terz

Novo Nordisk submitted a New Drug Application to the FDA in December 2025, and review is expected during 2026

They were developed and are manufactured by different companies